BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24421077)

  • 1. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.
    Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA
    Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
    Sher DJ; Neville BA; Chen AB; Schrag D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Beadle BM; Liao KP; Giordano SH; Garden AS; Hutcheson KA; Lai SY; Guadagnolo BA
    Cancer; 2017 Jan; 123(2):283-293. PubMed ID: 27662641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma.
    Pollom EL; Wang G; Harris JP; Koong AC; Bendavid E; Bhattacharya J; Chang DT
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):177-185. PubMed ID: 28258896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer.
    Yu JB; Soulos PR; Sharma R; Makarov DV; Decker RH; Smith BD; Desai RA; Cramer LD; Gross CP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e101-7. PubMed ID: 22342095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMRT for head and neck cancer: Cost implications.
    Razfar A; Mundi J; Grogan T; Lee S; Elashoff D; Abemayor E; St John M
    Am J Otolaryngol; 2016; 37(6):479-483. PubMed ID: 27968955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
    Boero IJ; Paravati AJ; Xu B; Cohen EE; Mell LK; Le QT; Murphy JD
    J Clin Oncol; 2016 Mar; 34(7):684-90. PubMed ID: 26729432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Lin SH; Zhang N; Godby J; Wang J; Marsh GD; Liao Z; Komaki R; Ho L; Hofstetter WL; Swisher SG; Mehran RJ; Buchholz TA; Elting LS; Giordano SH
    Cancer; 2016 Mar; 122(6):917-28. PubMed ID: 26716915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
    Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
    Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
    Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
    Kamal M; Mohamed ASR; Fuller CD; Sturgis EM; Johnson FM; Morrison WH; Gunn GB; Hutcheson KA; Phan J; Volpe S; Ng SP; Ferrarotto R; Frank SJ; Skinner HD; Rosenthal DI; Garden AS
    Cancer; 2018 Apr; 124(7):1415-1427. PubMed ID: 29338089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
    Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
    Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
    Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
    Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
    Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
    Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy "better" than step-and-shoot IMRT?
    Chen AM; Marsano J; Perks J; Farwell G; Luu Q; Donald PJ; Purdy JA
    Technol Cancer Res Treat; 2011 Apr; 10(2):171-7. PubMed ID: 21381795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.